Lonza Group AG: Leading Chemical Manufacturer and Innovator in Bio-Pharmaceutical Products, Nutritional Ingredients, and More

2023-10-13 07:01:06

Lonza Group AG is one of the world leaders in the development, manufacturing and marketing of chemicals. Turnover by product family is broken down as follows: – bio-pharmaceutical products (49.9%): exclusive syntheses, microbiological fermentation products, mammalian cell cultures, etc. ; – capsules and dosing solutions for biopharmaceutical products, medicines and nutrition products (22.3%). Furthermore, the group offers nutritional ingredients; – small molecule medicinal substances (14.2%); – technologies and platforms enabling the implementation of manufacturing processes and production of cell and gene therapies (11.1%); – others (2.5%). The geographical distribution of turnover is as follows: Switzerland (12.1%), Europe (31.9%), United States (39.1%), Americas (2.1%), Asia (12.4%) , Latin America (2%), Australia and New Zealand (0.3%) and others (0.1%).

More information regarding the company

1697184135
#Lonza #Group #add #filling #line #Swiss #site #October #a.m

Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

Red Wings Fall to Devils in High-Scoring Season Opener: Game Recap and Highlights

Tax Regularization and Amnesty Procedure: The Latest Updates and Proposed Changes in Belgium

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.